Summary
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company.
The global Biosimilars market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.
Further key aspects of the report indicate that:
Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
Chapter 2: Global Production & Consumption Market by Type and End-Use
Chapter 3: Europe Production & Consumption Market by Type and End-Use
Chapter 4: America Production & Consumption Market by Type and End-Use
Chapter 5: Asia Production & Consumption Market by Type and End-Use
Chapter 6: Oceania Production & Consumption Market by Type and End-Use
Chapter 7: Africa Production & Consumption Market by Type and End-Use
Chapter 8: Global Market Forecast by Type, End-Use and Region
Chapter 9: Company information, Sales, Cost, Margin, news etc.
Chapter 10: Market Competition by Companies and Market Concentration Ratio
Chapter 11: Market Impact by Coronavirus.
Chapter 12: Industry Summary
.
Market Segment as follows:
Key Companies
Sandoz International
Hospira
Teva Pharmaceutical
Dr. Reddy's Laboratories
Biocon
Mylan
Amgen
Celltrion
Roche Diagnostics
Merck KGaA
Key Types
Injection
Tablets
Others
Key End-Use
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
This report can be dispatched within 24-48 Hours.
Table of Contents
CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Biosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Biosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaBiosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Biosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Biosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Biosimilars Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Biosimilars Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Biosimilars Revenue by Type, 2015-2020 (Million USD)
Figure Global Biosimilars Revenue Share by Type in 2020 (Million USD)
Table Global Biosimilars Production Volume by Type, 2015-2020 (Volume)
Figure Global Biosimilars Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Biosimilars Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Biosimilars Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
Table Global Biosimilars Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 Europe MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Biosimilars Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Biosimilars Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Biosimilars Revenue by Type, 2015-2020 (Million USD)
Figure Europe Biosimilars Revenue Share by Type in 2020 (Million USD)
Table Europe Biosimilars Production Volume by Type, 2015-2020 (Volume)
Figure Europe Biosimilars Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Biosimilars Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Biosimilars Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Biosimilars Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Biosimilars Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Biosimilars Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Biosimilars Revenue by Type, 2015-2020 (Million USD)
Figure America Biosimilars Revenue Share by Type in 2020 (Million USD)
Table America Biosimilars Production Volume by Type, 2015-2020 (Volume)
Figure America Biosimilars Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
Table America Biosimilars Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Biosimilars Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
Table America Biosimilars Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Biosimilars Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Biosimilars Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Biosimilars Revenue by Type, 2015-2020 (Million USD)
Figure Asia Biosimilars Revenue Share by Type in 2020 (Million USD)
Table Asia Biosimilars Production Volume by Type, 2015-2020 (Volume)
Figure Asia Biosimilars Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Biosimilars Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Biosimilars Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Biosimilars Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Biosimilars Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Biosimilars Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Biosimilars Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Biosimilars Revenue Share by Type in 2020 (Million USD)
Table Oceania Biosimilars Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Biosimilars Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Biosimilars Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Biosimilars Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Biosimilars Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Biosimilars Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Biosimilars Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Biosimilars Revenue by Type, 2015-2020 (Million USD)
Figure Africa Biosimilars Revenue Share by Type in 2020 (Million USD)
Table Africa Biosimilars Production Volume by Type, 2015-2020 (Volume)
Figure Africa Biosimilars Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Biosimilars Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Biosimilars Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Biosimilars Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Biosimilars Production Forecast
Figure Global Biosimilars Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Biosimilars Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Biosimilars Forecast by Type
Table Global Biosimilars Revenue by Type, 2020E-2025F (Million USD)
Figure Global Biosimilars Revenue Share by Type in 2025 (Million USD)
Table Global Biosimilars Production Volume by Type, 2020E-2025F (Volume)
Figure Global Biosimilars Production Volume Share by Type in 2025 (Volume)
8.3 Global Biosimilars Forecast by End-Use (2020E-2025F)
Table Global Biosimilars Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Biosimilars Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Biosimilars Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Biosimilars Forecast by Region (2020E-2025F)
Table Global Biosimilars Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Biosimilars Consumption Value Share by Region in 2025 (Million USD)
Table Global Biosimilars Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Biosimilars Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Sandoz International
9.1.1 Sandoz International Profile
Table Sandoz International Overview List
9.1.2 Sandoz International Products & Services
9.1.3 Sandoz International Company Dynamics & News
9.1.4 Sandoz International Business Operation Conditions
Table Business Operation of Sandoz International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Hospira
9.2.1 Hospira Profile
Table Hospira Overview List
9.2.2 Hospira Products & Services
9.2.3 Hospira Company Dynamics & News
9.2.4 Hospira Business Operation Conditions
Table Business Operation of Hospira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Teva Pharmaceutical
9.3.1 Teva Pharmaceutical Profile
Table Teva Pharmaceutical Overview List
9.3.2 Teva Pharmaceutical Products & Services
9.3.3 Teva Pharmaceutical Company Dynamics & News
9.3.4 Teva Pharmaceutical Business Operation Conditions
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Dr. Reddy's Laboratories
9.4.1 Dr. Reddy's Laboratories Profile
Table Dr. Reddy's Laboratories Overview List
9.4.2 Dr. Reddy's Laboratories Products & Services
9.4.3 Dr. Reddy's Laboratories Company Dynamics & News
9.4.4 Dr. Reddy's Laboratories Business Operation Conditions
Table Business Operation of Dr. Reddy's Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Biocon
9.5.1 Biocon Profile
Table Biocon Overview List
9.5.2 Biocon Products & Services
9.5.3 Biocon Company Dynamics & News
9.5.4 Biocon Business Operation Conditions
Table Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Mylan
9.6.1 Mylan Profile
Table Mylan Overview List
9.6.2 Mylan Products & Services
9.6.3 Mylan Company Dynamics & News
9.6.4 Mylan Business Operation Conditions
Table Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Amgen
9.7.1 Amgen Profile
Table Amgen Overview List
9.7.2 Amgen Products & Services
9.7.3 Amgen Company Dynamics & News
9.7.4 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Celltrion
9.8.1 Celltrion Profile
Table Celltrion Overview List
9.8.2 Celltrion Products & Services
9.8.3 Celltrion Company Dynamics & News
9.8.4 Celltrion Business Operation Conditions
Table Business Operation of Celltrion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Roche Diagnostics
9.9.1 Roche Diagnostics Profile
Table Roche Diagnostics Overview List
9.9.2 Roche Diagnostics Products & Services
9.9.3 Roche Diagnostics Company Dynamics & News
9.9.4 Roche Diagnostics Business Operation Conditions
Table Business Operation of Roche Diagnostics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Merck KGaA
9.10.1 Merck KGaA Profile
Table Merck KGaA Overview List
9.10.2 Merck KGaA Products & Services
9.10.3 Merck KGaA Company Dynamics & News
9.10.4 Merck KGaA Business Operation Conditions
Table Business Operation of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Biosimilars Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Biosimilars Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Biosimilars Sales Volume by Companies, 2015-2020E (Volume)
Table Global Biosimilars Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Biosimilars Market Concentration Ratio in 2020E
Figure America Biosimilars Market Concentration Ratio in 2020E
Figure Asia Biosimilars Market Concentration Ratio in 2020E
Figure Oceania Biosimilars Market Concentration Ratio in 2020E
Figure Africa Biosimilars Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON Biosimilars INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 Biosimilars INDUSTRY SUMMARY & CONCLUSION
List of Table
Table Global Biosimilars Revenue by Type, 2015-2020 (Million USD)
Table Global Biosimilars Production Volume by Type, 2015-2020 (Volume)
Table Global Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Biosimilars Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
Table Global Biosimilars Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Biosimilars Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Biosimilars Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Biosimilars Revenue by Type, 2015-2020 (Million USD)
Table Europe Biosimilars Production Volume by Type, 2015-2020 (Volume)
Table Europe Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Biosimilars Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Biosimilars Consumption Volume by Region, 2015-2020 (Volume)
Table America Biosimilars Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Biosimilars Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Biosimilars Revenue by Type, 2015-2020 (Million USD)
Table America Biosimilars Production Volume by Type, 2015-2020 (Volume)
Table America Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Biosimilars Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
Table America Biosimilars Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Biosimilars Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Biosimilars Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Biosimilars Revenue by Type, 2015-2020 (Million USD)
Table Asia Biosimilars Production Volume by Type, 2015-2020 (Volume)
Table Asia Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Biosimilars Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Biosimilars Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Biosimilars Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Biosimilars Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Biosimilars Revenue by Type, 2015-2020 (Million USD)
Table Oceania Biosimilars Production Volume by Type, 2015-2020 (Volume)
Table Oceania Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Biosimilars Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Biosimilars Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Biosimilars Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Biosimilars Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Biosimilars Revenue by Type, 2015-2020 (Million USD)
Table Africa Biosimilars Production Volume by Type, 2015-2020 (Volume)
Table Africa Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Biosimilars Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Biosimilars Consumption Volume by Region, 2015-2020 (Volume)
Table Global Biosimilars Revenue by Type, 2020E-2025F (Million USD)
Table Global Biosimilars Production Volume by Type, 2020E-2025F (Volume)
Table Global Biosimilars Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Biosimilars Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Biosimilars Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Biosimilars Consumption Volume by Region, 2020E-2025F (Volume)
Table Sandoz International Overview List
Table Business Operation of Sandoz International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hospira Overview List
Table Business Operation of Hospira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Overview List
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Reddy's Laboratories Overview List
Table Business Operation of Dr. Reddy's Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biocon Overview List
Table Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Overview List
Table Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celltrion Overview List
Table Business Operation of Celltrion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Diagnostics Overview List
Table Business Operation of Roche Diagnostics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck KGaA Overview List
Table Business Operation of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Biosimilars Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Biosimilars Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Biosimilars Sales Volume by Companies, 2015-2020E (Volume)
Table Global Biosimilars Sales Volume Share by Companies, 2015-2020E (Volume)
List of Figure
Figure Europe Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Biosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Biosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaBiosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Biosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Biosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Biosimilars Revenue Share by Type in 2020 (Million USD)
Figure Global Biosimilars Production Volume Share by Type in 2020 (Volume)
Figure Global Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Biosimilars Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Biosimilars Revenue Share by Type in 2020 (Million USD)
Figure Europe Biosimilars Production Volume Share by Type in 2020 (Volume)
Figure Europe Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Biosimilars Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Biosimilars Revenue Share by Type in 2020 (Million USD)
Figure America Biosimilars Production Volume Share by Type in 2020 (Volume)
Figure America Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Biosimilars Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Biosimilars Revenue Share by Type in 2020 (Million USD)
Figure Asia Biosimilars Production Volume Share by Type in 2020 (Volume)
Figure Asia Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Biosimilars Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Biosimilars Revenue Share by Type in 2020 (Million USD)
Figure Oceania Biosimilars Production Volume Share by Type in 2020 (Volume)
Figure Oceania Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Biosimilars Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Biosimilars Revenue Share by Type in 2020 (Million USD)
Figure Africa Biosimilars Production Volume Share by Type in 2020 (Volume)
Figure Africa Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Biosimilars Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Biosimilars Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Biosimilars Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Biosimilars Revenue Share by Type in 2025 (Million USD)
Figure Global Biosimilars Production Volume Share by Type in 2025 (Volume)
Figure Global Biosimilars Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Biosimilars Consumption Value Share by Region in 2025 (Million USD)
Figure Global Biosimilars Consumption Volume Share by Region in 2025 (Volume)
Asia Pacific bioprocess technology market will grow by 15.0% annually with a total addressable market cap of $170.71 billion over 2024-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology...
Europe bioprocess technology market was valued at $6.56 billion in 2023 and will grow by 13.7% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing tech...
North America bioprocess technology market is projected to grow by 13.3% annually in the forecast period and reach $29.68 billion by 2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology s...
Global bioprocess technology market will reach $88.39 billion by 2033, growing by 13.8% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing technologic...
Asia Pacific biopharmaceuticals market will grow by 10.3% annually with a total addressable market cap of $1,776.7 billion over 2024-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discove...
Europe biopharmaceuticals market was valued at $116.5 billion in 2023 and will grow by 8.6% annually over 2023-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing clinical t...
North America biopharmaceuticals market is projected to grow by 8.4% annually in the forecast period and reach $407.2 billion by 2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, ...
Global biopharmaceuticals market will reach $1,001.1 billion by 2033, growing by 8.8% annually over 2023-2033. The growth is driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing cl...
Overview of the Global Biosimilars & Follow-on-Biologics Market:
The report discusses everything a marketer requires before investing in the global Biosimilars & Follow-on-Biologics Market during the forecast period...
The global Biosimilars market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field ev...